Position in PHVS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$874,394
+$107,384 QoQ
Shares Held
30,952
+12.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Amundi holds $2,277,505,863 across 70 Biotechnology names. PHVS ranks #25 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,009,798 | $780,210,323 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,472,496 | $657,528,360 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
747,544 | $247,339,881 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,088,773 | $148,168,440 | |
| 5 | INSM |
INSMED Inc
|
804,977 | $131,629,838 | |
| 6 | INCY |
Incyte Corp
|
1,003,969 | $94,493,561 | |
| 7 | MRNA |
Moderna, Inc.
|
904,823 | $45,965,008 | |
| 8 | ARGX |
Argenx SE
|
61,433 | $44,861,448 |
All Filings in PHVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $874,394 | 30,952 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $767,010 | 27,640 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,035,849 | 41,517 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $482,539 | 27,417 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $15 | 1 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,741 | 143 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,555 | 84 | Shares | Defined | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||